RB1 and Familial retinoblastoma: All patients with bilateral, trilateral or familial retinoblastoma have to be considered as carriers of a heritable tumor predisposition syndrome, even if no molecular genetic analysis was performed or in the absence of detection of the oncogenic RB1 variant in blood DNA.